| Dr Erin T Steidl, MD | |
|
111 Highway 70 E, Suite H, Dickson, TN 37055-2080 | |
| (615) 446-4400 | |
| (615) 446-4234 |
| Full Name | Dr Erin T Steidl |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 111 Highway 70 E, Dickson, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407065675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VH0002X | Obstetrics & Gynecology - Hospice And Palliative Medicine | BP1-0016939 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Horizon Medical Center | Dickson, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Health Center Of Dickson | 2860477940 | 2 |
News Archive
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
Cell, the most prestigious international journal in the field of biology, is today publishing a set of three papers on renal cancer. Among the authors of these papers is Dr José Ignacio López, head of the Pathological Anatomy Service of University Hospital Cruces and tenured lecturer in Pathological Anatomy at the UPV/EHU's Faculty of Medicine and Nursing.
The Endocrine Society lauds Novo Nordisk's recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue.
A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA). RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.
› Verified 3 days ago
| Entity Name | Womens Health Center Of Dickson |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194761551 PECOS PAC ID: 2860477940 Enrollment ID: O20080222000148 |
News Archive
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
Cell, the most prestigious international journal in the field of biology, is today publishing a set of three papers on renal cancer. Among the authors of these papers is Dr José Ignacio López, head of the Pathological Anatomy Service of University Hospital Cruces and tenured lecturer in Pathological Anatomy at the UPV/EHU's Faculty of Medicine and Nursing.
The Endocrine Society lauds Novo Nordisk's recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue.
A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA). RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin T Steidl, MD 111 Highway 70 E, Suite H, Dickson, TN 37055-2080 Ph: (615) 446-4400 | Dr Erin T Steidl, MD 111 Highway 70 E, Suite H, Dickson, TN 37055-2080 Ph: (615) 446-4400 |
News Archive
Oxygen Biotherapeutics, Inc. has announced that enrollment for the company's first dermatological study will begin later this month at St. John's Medical College Hospital in Bangalore, India. The company received formal approval from the hospital's Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.
Cell, the most prestigious international journal in the field of biology, is today publishing a set of three papers on renal cancer. Among the authors of these papers is Dr José Ignacio López, head of the Pathological Anatomy Service of University Hospital Cruces and tenured lecturer in Pathological Anatomy at the UPV/EHU's Faculty of Medicine and Nursing.
The Endocrine Society lauds Novo Nordisk's recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue.
A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA). RFA, which uses localized thermal energy to kill cancer cells, is increasingly used as an alternative treatment for patients unable to undergo surgery or other therapies to treat lung cancer.
› Verified 3 days ago
Jenna Peplinski, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 111 Highway 70 E Ste 201, Dickson, TN 37055 Phone: 615-560-1333 | |
Dr. Michael Darren Hawkins, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 Hwy 70 E, Suite H, Dickson, TN 37055 Phone: 615-446-4400 Fax: 615-446-4234 |